Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community

Lancet. 1977 Jun 25;1(8026):1338-41. doi: 10.1016/s0140-6736(77)92552-1.

Abstract

A double-blind controlled trial of a 14-valent pneumococcal polysaccharide vaccine was carried out in 11 958 adults at Tari in the Papua New Guinea Highlands. Pneumococcal infection, confirmed by blood-culture and lung aspirate, was less in the vaccinated group by 84%. Mortality from pneumonia was less by 44%.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Antibodies, Bacterial / isolation & purification
  • Bacterial Vaccines / administration & dosage
  • Bacterial Vaccines / therapeutic use*
  • Clinical Trials as Topic
  • Evaluation Studies as Topic
  • Follow-Up Studies
  • Humans
  • Lung / microbiology
  • New Guinea
  • Nose / microbiology
  • Pneumonia, Pneumococcal / microbiology
  • Pneumonia, Pneumococcal / mortality
  • Pneumonia, Pneumococcal / prevention & control*
  • Polysaccharides, Bacterial / administration & dosage
  • Polysaccharides, Bacterial / therapeutic use
  • Sepsis / microbiology
  • Sputum / microbiology
  • Streptococcus pneumoniae / immunology*
  • Streptococcus pneumoniae / isolation & purification

Substances

  • Antibodies, Bacterial
  • Bacterial Vaccines
  • Polysaccharides, Bacterial